Status: Recruiting
VCA Regimen Followed by D-MAG Regimen on the Treatment of Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
The purpose of this study is to evaluate the safety and efficacy of Venetoclax Combining Chidamide and Azacitidine (VCA) Followed by D-MAG Regimen on the Treatment of Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
Participants needed: 66
Trial details
Phase: Phase 2Age: 60+Biological sex: AllType: InterventionalSponsor: The First Affiliated Hospital of Xiamen UniversityUpdated: Feb 19, 2025Locations: 1
Eligibility criteria
1) Histologically confirmed acute myeloid leukemia (non-M3). Treatment-na?ve and...
1)Acute promyelocytic leukemia (APL) and low risk cytogenetics such as t(8;21),...